Winton Group LTD Meridian Bioscience Inc Transaction History

Winton Group LTD

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$31.15 - $33.39 $371,027 - $397,708	11,911 Added 18.98%	74,675 $2.48 Million
Q3 2022 Nov 10, 2022	BUY	$30.9 - $33.55 $1.47 Million - $1.6 Million	47,679 Added 316.07%	62,764 $1.98 Million
Q2 2022 Aug 10, 2022	BUY	$23.75 - $31.69 $358,268 - $478,043	15,085 New	15,085 $459,000
Q1 2021 Jul 21, 2021	SELL	$19.76 - $29.89 $217,656 - $329,238	-11,015 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$15.73 - $21.66 $173,265 - $238,584	11,015 New	11,015 $206,000
Q2 2020 Aug 05, 2020	SELL	$7.84 - $23.29 $1.59 Million - $4.72 Million	-202,869 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$5.57 - $11.5 $449,877 - $928,832	80,768 Added 66.15%	202,869 $1.7 Million
Q4 2019 Feb 13, 2020	BUY	$7.9 - $10.14 $575,831 - $739,104	72,890 Added 148.12%	122,101 $1.19 Million
Q3 2019 Nov 08, 2019	BUY	$9.17 - $12.01 $191,882 - $251,309	20,925 Added 73.98%	49,211 $467,000
Q2 2019 Jul 08, 2019	BUY	$10.88 - $17.6 $307,751 - $497,833	28,286 New	28,286 $336,000
Q1 2019 May 13, 2019	SELL	$15.51 - $17.61 $3.33 Million - $3.78 Million	-214,511 Closed	0 $0
Q4 2018 Feb 05, 2019	BUY	$14.52 - $19.72 $3.11 Million - $4.23 Million	214,511 New	214,511 $3.72 Million

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.